Atlas Trials

Medigen Vaccine Biologics Corp.

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Medigen Vaccine Biologics Corp.

RecordFirmDate
Long-Term Immunogenicity of Envacgen® in Children (NCT07568522)Medigen Vaccine Biologics Corp.2025-11-24
A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years (NCT07178522)Medigen Vaccine Biologics Corp.2025-06-25
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above (NCT05198596)Medigen Vaccine Biologics Corp.2022-07-30
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222 (NCT05426343)Medigen Vaccine Biologics Corp.2022-07-09
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19 (NCT05216601)Medigen Vaccine Biologics Corp.2022-05-06
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19 (NCT05197153)Medigen Vaccine Biologics Corp.2022-01-22
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults (NCT05011526)Medigen Vaccine Biologics Corp.2021-10-08
A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study (NCT05038618)Medigen Vaccine Biologics Corp.2021-08-02
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents (NCT04951388)Medigen Vaccine Biologics Corp.2021-07-22
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study (NCT05048849)Medigen Vaccine Biologics Corp.2021-07-19
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults (NCT04822025)Medigen Vaccine Biologics Corp.2021-05-20
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (NCT04695652)Medigen Vaccine Biologics Corp.2020-12-30
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 (NCT04487210)Medigen Vaccine Biologics Corp.2020-10-07
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children (NCT04072276)Medigen Vaccine Biologics Corp.2019-08-15
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine (NCT03865238)Medigen Vaccine Biologics Corp.2019-04-23
A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (NCT03718468)Medigen Vaccine Biologics Corp.2018-10-30

Track Medigen Vaccine Biologics Corp. automatically

Every clearance here is in the API, with alerts when new ones post.